On November 1st, Gelonghui reported that Hubo Pharmaceutical-B (02142.HK) announced the repurchase of 0.132 million shares for 0.1578 million Hong Kong dollars on November 1, 2024, at a repurchase price of 1.18-1.21 Hong Kong dollars per share.
和铂医药-B(02142.HK)11月1日耗资15.78万港元回购13.2万股
WuXi Biologics-B (02142.HK) spent 0.1578 million Hong Kong dollars on November 1st to repurchase 0.132 million shares.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.